Recurrent Lung Squamous Cell Carcinoma

Also known as: Recurrent Squamous Cell Lung Carcinoma / Lung squamous cell carcinoma recurrent

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB01248	Docetaxel	1 / 2	Withdrawn	1
DB01175	Escitalopram	1 / 2	Withdrawn	1
DB11942	Selinexor	1 / 2	Withdrawn	1
DB11714	Durvalumab	2	Completed	1
DB11836	Sapanisertib	2	Completed	1
DB11760	Talazoparib	2	Completed	1
DB12108	Taselisib	2	Completed	1
DB15104	Telisotuzumab vedotin	2	Completed	1
DB11771	Tremelimumab	2	Completed	1
DB18442	ABSK-091	2 / 3	Completed	1
DB01248	Docetaxel	2 / 3	Completed	3
DB11714	Durvalumab	2 / 3	Completed	1
DB00530	Erlotinib	2 / 3	Terminated	1
DB09073	Palbociclib	2 / 3	Completed	1
DB11972	Rilotumumab	2 / 3	Terminated	1
DB00112	Bevacizumab	3	Terminated	1
DB00958	Carboplatin	3	Terminated	1
DB00002	Cetuximab	3	Terminated	1
DB06186	Ipilimumab	3	Active Not Recruiting	1
DB06132	Nivolumab	3	Active Not Recruiting	1
DB09035	Nivolumab	3	Active Not Recruiting	1
DB01229	Paclitaxel	3	Terminated	1
DB18442	ABSK-091	Not Available	Completed	1
DB01248	Docetaxel	Not Available	Completed	1
DB11714	Durvalumab	Not Available	Completed	1
DB00530	Erlotinib	Not Available	Completed	1
DB06186	Ipilimumab	Not Available	Completed	1
DB09035	Nivolumab	Not Available	Completed	1
DB09073	Palbociclib	Not Available	Completed	1
DB11972	Rilotumumab	Not Available	Completed	1
DB11760	Talazoparib	Not Available	Completed	1
DB12108	Taselisib	Not Available	Completed	1
DB11771	Tremelimumab	Not Available	Completed	1